brimonidine tartrate has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dooley, DJ; Hertting, G; Lupp, A; Osswald, H | 1 |
| Gendron, ME; Perrault, LP; Thorin, E | 1 |
2 other study(ies) available for brimonidine tartrate and oxadiazoles
| Article | Year |
|---|---|
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.
Topics: Aminopyridines; Animals; Brimonidine Tartrate; Cadmium; Calcium Channel Blockers; Dioxanes; Hippocampus; Idazoxan; In Vitro Techniques; Mollusk Venoms; Neomycin; Nicotinic Acids; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Phorbol Esters; Quinoxalines; Rabbits | 1988 |
Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy.
Topics: Adenosine Triphosphate; Animals; Bradykinin; Brimonidine Tartrate; Canada; Charybdotoxin; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Endocardium; Endothelium, Vascular; Glyburide; Guanylate Cyclase; Hemodynamics; Hypertrophy, Left Ventricular; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oxadiazoles; Potassium Channels; Quinoxalines; Swine; Vascular Resistance; Vasodilation | 2004 |